Institutions / Ishara Investments LP
Ishara Investments LP
CIK 2111609 · Institution · as of Dec 31, 2025
Portfolio value
$85.92M
Positions
37
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 37 →
| Company | Value | % of portfolio |
|---|---|---|
| Praxis Precision Medicines, Inc. | $11.79M | 13.7% |
| Xeris Biopharma Holdings, Inc. | $6.28M | 7.3% |
| BioMarin Pharmaceutical Inc | $5.94M | 6.9% |
| Amicus Therapeutics Inc | $5.13M | 6.0% |
| ACADIA Pharmaceuticals Inc | $4.27M | 5.0% |
| Annexon, Inc. | $3.77M | 4.4% |
| Nuvation Bio Inc.NUVB | $3.58M | 4.2% |
| BridgeBio Pharma, Inc. | $2.75M | 3.2% |
| PTC Therapeutics Inc | $2.73M | 3.2% |
| United Therapeutics Corp | $2.68M | 3.1% |
| Biocryst Pharmaceuticals Inc | $2.34M | 2.7% |
| Vaxcyte, Inc. | $2.31M | 2.7% |
| Genmab A/S | $2.16M | 2.5% |
| Syndax Pharmaceuticals Inc | $2.10M | 2.4% |
| Verastem, Inc. | $2.08M | 2.4% |
| Tarsus Pharmaceuticals, Inc. | $1.97M | 2.3% |
| Apogee Enterprises, Inc. | $1.89M | 2.2% |
| Zentalis Pharmaceuticals, Inc.ZNTL | $1.78M | 2.1% |
| Insmed Inc | $1.74M | 2.0% |
| Silence Therapeutics plcSLN | $1.46M | 1.7% |
| Edgewise Therapeutics, Inc. | $1.44M | 1.7% |
| Beam Therapeutics Inc. | $1.39M | 1.6% |
| Oric Pharmaceuticals, Inc. | $1.31M | 1.5% |
| Apellis Pharmaceuticals, Inc. | $1.26M | 1.5% |
| Denali Therapeutics Inc. | $1.16M | 1.3% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.